Repositorio
Cómo publicar
Recursos
FAQs

Mostrar el registro sencillo del ítem

CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis

dc.contributor.authorMasson Lecomte, A.
dc.contributor.authorMaillé, P.
dc.contributor.authorPineda, S.
dc.contributor.authorSoyeux, P.
dc.contributor.authorSagrera, A.
dc.contributor.authorRava, M.
dc.contributor.authorLópez de Maturana, E.
dc.contributor.authorMárquez, M.
dc.contributor.authorTardón García, Adonina 
dc.contributor.authorCarrato, A.
dc.contributor.authorKogevinas, M.
dc.contributor.authorde la Taille, A.
dc.contributor.authorHartmann, A.
dc.contributor.authorMalats, N.
dc.contributor.authorReal, P.
dc.contributor.authorAllory, Y.
dc.date.accessioned2020-01-23T08:17:44Z
dc.date.available2020-01-23T08:17:44Z
dc.date.issued2019
dc.identifier.citationBladder Cancer, 5(2), p. 159-169 (2019); doi:10.3233/BLC-180206
dc.identifier.issn2352-3727
dc.identifier.urihttp://hdl.handle.net/10651/53825
dc.description.sponsorshipThe work was partially supported by Fondo de Investigaciones Sanitarias (FIS, #PI00-0745, #PI05-1436, and #PI06-1614) and Red Tematica ´ de Investigacion Cooperativa en C ´ ancer (RTICC, ´ #RD12/0036/0050 and #RD12/0036/0034), Instituto de Salud Carlos III; and Asociacion Espa ´ nola ˜ Contra el Cancer (AECC), Spain; the Intramu- ´ ral Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA (Contract NCI NO2-CP-11015); and EU-FP7-HEALTH-F2-2008-201663-UROMOL and EU-7FP-HEALTH-TransBioBC #601933. AML was funded by a fellowship of the European Urological Scholarship Program from the European Association of Urology (EUSP Scholarship S-01-2013).
dc.format.extentp. 159-169
dc.language.isoeng
dc.relation.ispartofBladder Cancer, 5
dc.rights© 2019 – IOS Press and the authors.
dc.rightsCC Reconocimiento - No Comercial - Sin Obra Derivada 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85071261194&doi=10.3233%2fBLC-180206&partnerID=40&md5=40878bf3a344d5e972a3eae33269302d
dc.titleCD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
dc.typejournal article
dc.identifier.doi10.3233/BLC-180206
dc.relation.projectIDFIS/PI00-0745
dc.relation.projectIDFIS/PI05-1436
dc.relation.projectIDFIS/PI06-1614
dc.relation.projectIDRTICC/RD12/0036/0050
dc.relation.projectIDEU-FP7-HEALTH-F2-2008-201663-UROMOL
dc.relation.publisherversionhttp://dx.doi.org/10.3233/BLC-180206
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated
Nombre:
CD8_Cytotoxic.pdf
Tamaño:
1.839Mb
Formato:
PDF
Descripción:
Versión final del editor

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2019 – IOS Press and the authors.
Este ítem está sujeto a una licencia Creative Commons